Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

Figure 1

Serum sRAGE, S100A9, S100A8 and S100A12 levels in rheumatoid arthritis (RA) patients and healthy controls. Levels of S100A12 (a), S100A9 (b), S100A8 (c), and soluble receptor for advanced glycation end products (sRAGE) (d) were measured in serum of 138 patients with established RA and 44 healthy controls by ELISA. The horizontal line represents the mean value. *** P < 0.001, * P < 0.05.

Back to article page